Upload Avatar (500 x 500)
Wei Xie
xie_wei@zju.edu.cn
Chinese, English
Zhejiang
Zhejiang University
Pharmaceutical Sciences
  • 2007 - Bachelor's Degree: Shandong University
  • 2013 - PhD: Institute of Biophysics, Chinese Academy of Sciences
  • Developed small molecule inhibitors targeting cGAS and novel STING agonists
  • 2013-2016 - Tianjin University - Lecturer
  • 2016-2021 - Memorial Sloan Kettering Cancer Center - Postdoctoral Researcher
  • 2021-Present - Zhejiang University - Researcher, Doctoral Supervisor
  • National High-Level Overseas Young Talent
Pharmacology of anti-infection/anti-tumor drugs based on nucleic acid recognition mechanisms
Intelligent molecular intervention and mechanism of action of important drug targets related to nucleic acids in immunity and infection
Drug discovery and molecular mechanisms
  • Advances in structure-guided mechanisms impacting on the cGAS-STING innate immune pathway, Chen KX, Liao JL, Patel DJ, Xie W, 2023
  • Arabinose- and xylose-modified analogs of 2′, 3′-cGAMP act as STING agonists, Xie W, Lama L, Yang XJ, Kuryavyi V, Bhattacharya S, Nudelman I, Yang GL, Ouerfelli O, Glickman JF, Jones RA, Tuschl T, Patel DJ, 2023
  • 细胞核内液-液相分离作为抗肿瘤药物靶点的研究进展, 陈维浩, 谭采薇, 赵青威, 谢伟, 2023
  • Structure-based mechanisms of 2'3'-cGAMP intercellular transport in the cGAS–STING immune pathway, Xie W, Patel DJ, 2023
  • cGAMP-activated cGAS–STING signaling: its bacterial origins and evolutionary adaptation by metazoans, Patel DJ, Yu Y, Xie W, 2023
  • A ‘warhorse-shaped’ topology adopted by the m6A RNA writer complex, Xie W, Patel DJ, 2023
  • Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells, Nguyenla X, Wehri E, Dis EV, Biering S, Yamashiro LH, Zhu C, Stroumza J, Dugast-Darzacq C, Graham TGW, Wang XT, Jockusch S, Tao CJ, Chien M, Xie W, Patel DJ, Meyer C, Garzia A, Tuschl T, Russo JJ, Ju JY, Näär AM, Stanley S, Schaletzky J, 2022
  • A structural platform for B cell receptor signaling, Xie W, Wucherpfennig K, Patel DJ, 2022
  • Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture, Wang XT, Sacramento CQ, Jockusch S, Chaves OA, Tao CJ, Fintelman-Rodrigues N, Chien M, Temerozo JR, Li X, Kumar S, Xie W, Patel DJ, Meyer C, Garzia A, Tuschl T, Bozza PT, Russo JJ, Souza TM, Ju JY, 2022
  • The transcriptional regulator HDP1 controls expansion of the inner membrane complex during early sexual differentiation of malaria parasites, Riward CM, Tong XR, Xie W, Abel S, Orchard LM, Daher W, Patel DJ, Llinás M, Le Roch KG, Kafsack B, 2022
  • m6A mRNA catalyzes a phase-separated nuclear body that controls differentiation, Cheng Y, Xie W, Pickering BF, Chu KL, Savino AM, Yang X, Luo H, Nguyen DT, Barin E, Velleca A, Rohwetter T, Patel DJ, Jaffrey SR, Kharas MG, 2021
  • In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19, Sacramento CQ, Fintelman-Rodrigues N, Temerozo JR, et al., 2021
  • DNA-driven condensation assembles the meiotic DNA break machinery, Bouuaert CC, Pu S, Wang J, Oger C, Daccache D, Xie W, Patel DJ, Keeney S, 2021
  • Molecular mechanisms of assembly and TRIP13-mediated remodeling of the human Shieldin complex, Xie W, Wang S, Wang J, de la Cruz MJ, Xu G, Scaltriti M, Patel DJ, 2021
  • The Card1 nuclease provides defence during type III CRISPR immunity, Rostøl JT, Xie W, Kuryavyi V, Maguin P, Kao K, Froom R, Patel DJ, Marraffini LA, 2021
  • In vivo reconstitution finds multivalent RNA–RNA interactions as drivers of mesh-like condensates, Ma W, Zhen G, Xie W, Mayr C, 2021
  • Structure-function analysis of microRNA 3′-end trimming by Nibbler, Xie W, Sowemimo I, Hayashi R, Wang J, Burkard TR, Brennecke J, Ameres SL, Patel DJ, 2020
  • Keeping innate immune response in check: when cGAS meets the nucleosome, Xie W, Patel DJ, 2020
  • Structure–function insights into the initial step of DNA integration by a CRISPR-Cas-Transposon complex, Jia N, Xie W, de la Cruz MJ, Eng ET, Patel DJ, 2020
  • REV7 has a dynamic adaptor region to accommodate small GTPase RAN/Shigella IpaB ligands, and its activity is regulated by RanGTP/GDP switch, Wang X, Pernicone N, Pertz L, Hua DP, Zhang TQ, Listovsky T, Xie W, 2019
  • The nascent RNA binding complex SFiNX licenses piRNA-guided heterochromatin formation, Batki J, Schnabl J, Wang J, Handler D, Andreev VI, Stieger CE, Novatchkova M, Lampersberger L, Kauneckaite K, Xie W, Karl M, Patel DJ, Brennecke J, 2019
  • Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia, Minuesa G, Albanese SK, Xie W, Kazansky Y, Worroll D, Chow A, Schurer A, Park SM, Rotsides CZ, Taggart J, Rizzi A, Naden LN, Chou T, Gourkanti S, Cappel D, Passarelli MC, Fairchild L, Adura C, Glickman JF, Schulman J, Famulare C, Patel M, Eibl JK, Ross GM, Bhattacharya S, Tan DS, Leslie CS, Beuming T, Patel DJ, Goldgur Y, Chodera JD, Kharas MG, 2019
  • Human cGAS catalytic domain has an additional DNA-binding interface that enhances enzymatic activity and liquid-phase condensation, Xie W, Lama L, Adura C, Glickman JF, Tuschl T, Patel DJ, 2019
  • Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression, Lama L, Adura C, Xie W, Tomita D, Kamei T, Kuryavyi V, Gogakos T, Steinberg JI, Miller M, Ramos-Espiritu L, Asano K, Hashizume S, Aida J, Imaeda T, Okamato R, Jennings AJ, Michino M, Kuroita T, Stamford A, Gao P, Meinkwe P, Glickman JF, Patel DJ, Tuschl T, 2019
  • TRF2 binds branched DNA to safeguard telomere integrity, Schmutz I, Timashev L, Xie W, Patel DJ, de Lange T, 2017
  • Structural studies of the periplasmic portion of the diguanylate cyclase CdgH from Vibrio cholerae, Xu M, Wang YZ, Yang XA, Jiang T, Xie W, 2017
  • A Mutation Identified in Neonatal Microcephaly Destabilizes Zika Virus NS1 Assembly in Vitro, Wang D, Chen C, Liu S, Zhou H, Yang K, Zhao Q, Ji X, Chen C, Xie W, Wang ZF, Mi LZ, Yang HT, 2017
  • The conformational changes of Zika virus methyltransferase upon converting SAM to SAH, Zhou H, Wang F, Wang H, Chen C, Zhang T, Han X, Wang D, Chen C, Wu C, Xie W, Wang ZF, Zhang L, Wang L, Yang HT, 2017
  • The crystal structure of Zika virus helicase: basis for antiviral drug design, Tian H, Ji X, Yang X, Xie W, Yang K, Chen C, Wu C, Chi H, Mu Z, Wang ZF, Yang HT, 2016
  • Structural basis of Zika virus helicase in recognizing its substrates, Tian H, Ji X, Yang X, Zhang Z, Lu Z, Yang K, Chen C, Zhao Q, Chi H, Mu Z, Xie W, Wang Z, Lou H, Yang HT, Rao ZH, 2016
  • Structural insight into the assembly of human anti-HIV dynamin-like protein MxB/Mx2, Xu B, Kong J, Wang X, Wei W, Xie W, Yu XF, 2015
  • Characterization of the amino-terminal domain of Mx2/MxB-dependent interaction with the HIV-1 capsid, Kong J, Xu B, Wei W, Wang X, Xie W, Yu XF, 2014
  • Structural insights into the assembly of human translesion polymerase complexes, Xie W, Yang X, Xu M, Jiang T, 2012
  • Structure and functional implications of the human Rad9-Hus1-Rad1 cell cycle checkpoint complex, Xu M, Bai L, Gong Y, Xie W, Hang H, Jiang T, 2009
Nucleic Acid Recognition Anti-Infection Anti-Tumor Pharmacology Immune Response Drug Targets Molecular Intervention Mechanism Of Action Drug Discovery Molecular Mechanisms

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.